{
}
UBS AG maintains a "Buy" rating for Symrise, setting a price target of 138 euros, following the company's raised margin outlook for 2024. Despite a recent 1.0% decline in share price to EUR 103.50, there remains a potential upside of 33.33%. Since the start of 2024, Symrise shares have increased by 5.0%, with Q4 2024 financial results expected on March 5, 2025.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a target price of 138 euros, indicating a potential upside of 33.59% from the current price of 103.30 euros. Analyst Charles Eden highlighted positive margin signals and the company's goal for higher profitability. Since the start of 2024, the share price has increased by 4.8%, with a daily trading volume of 65,606 shares.
UBS has maintained a "Neutral" rating on Givaudan shares with a target price of 4,520 francs. Following an in-depth review, Givaudan's stock fell 1.8% to CHF 3,774.00, indicating a potential upside of 19.77%. The company is set to release its Q4 2024 results on January 24, 2025.
UBS has maintained a 'Neutral' rating for Givaudan, setting a target price of 4,520 Swiss francs. Analyst Charles Eden also highlighted DMS-Firmenich, Symrise, and Croda as attractive investment options in the flavor and fragrance sector for the upcoming quarter.
UBS AG maintains a "Buy" rating for Symrise with a target price of €138, anticipating positive developments from the upcoming Capital Markets Day. Despite a 0.3% decline in share price to €104.00, there remains a 32.69% upside potential. Symrise shares have increased by 5.5% since the start of 2024, with Q4 2024 results expected on March 5, 2025.
UBS has maintained a 'Buy' rating for Symrise, setting a price target of 138 euros. Analyst Charles Eden highlighted the company as a key player in the flavor and fragrance sector, anticipating positive developments from the upcoming capital market day. Symrise, a leader in fragrances and flavors, generates 63% of its sales from nutritional ingredients and has a diverse geographical sales distribution.
UBS has maintained a "Neutral" rating for Givaudan, setting a target price of 4,520 francs. Analyst Charles Eden identified DMS-Firmenich, Symrise, and Croda as attractive investment options in the flavor and fragrance sector during the final quarter reporting season.
UBS has maintained a "Buy" rating for Symrise, setting a target price of 138 euros. Analyst Charles Eden noted the stock's potential for positive price drivers ahead of the upcoming Capital Markets Day, highlighting it as one of three noteworthy picks in the flavor and fragrance sector.
UBS has maintained a 'Buy' rating for Symrise, setting a price target of 138 euros. Analyst Charles Eden noted the potential for positive price drivers from the upcoming Capital Markets Day, highlighting Symrise among key stocks to watch in the flavor and fragrance sector. As of November 15, 2024, Symrise shares were trading at approximately 103.75 euros, reflecting a slight decline of 0.57%.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 138 euros, indicating a potential upside of 32.69% from the current price of 104 euros. Analyst Charles Eden anticipates positive developments from the upcoming Capital Markets Day, with Symrise's Q4 2024 results expected on March 5, 2025. The stock has seen a 5.5% increase since the start of 2024, with 125,525 shares traded recently on XETRA.
Symrise AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for symrise with price target of 138 euros
17:43 20.11.2024
UBS maintains buy rating for Symrise with target price of 138 euros
18:57 19.11.2024
ubs maintains neutral rating on givaudan shares with target price of 4520 francs
14:43 15.11.2024
ubs maintains neutral rating for givaudan with target price of 4520 francs
14:42 15.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
14:37 15.11.2024
UBS maintains buy rating for Symrise with target price of 138 euros
14:30 15.11.2024
ubs maintains neutral rating for givaudan with target price of 4520 francs
13:54 15.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
13:49 15.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
13:49 15.11.2024
ubs maintains buy rating for symrise with price target of 138 euros
13:37 15.11.2024
Trending
Subcategory
Startups & Entrepreneurship
Industry Trends
Corporate News
Private Equity Deals
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
CEO Changes
Government Economic Policies
Corporate Social Responsibility
Industry Mergers & Acquisitions
Workplace Trends
Energy Sector Developments
Venture Capital Investments
Fintech Startups
Finance Mergers & Acquisitions
AI Innovations
Market Analysis and Predictions
Intellectual Property Laws
Central Bank Actions
Countries:
Companies:
Apple Inc.
NVIDIA Corporation
Google Inc.
Amazon.com, Inc.
Tesla, Inc.
Salesforce, Inc.
Garuda Aerospace Ltd.
Huawei Technologies CO. Ltd.
Bharti Airtel Ltd.
XPeng Inc.
Microsoft Corporation
Venturewave Capital NO.1 Ltd.
Semler Scientific, Inc.
TENCENT
Wipro Ltd
OpenAI ERC USD
Orange S.A.
IDBI Bank Limited
Standard Chartered Bank
LENOVO GROUP
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Saudi Riyal
Japanese Yen
Malaysian Ringgit
British Pound Sterling
Mexican Peso
Brazilian Real
New Taiwan Dollar
Bahraini Dinar
Qatari Riyal
Pakistani Rupee
Kuwaiti Dinar
Vietnamese Đồng
South Korean Won
Algerian Dinar
People:
Donald Trump
Mark Zuckerberg
Bisrat Degefa
He Xiaopeng
Abdel Fattah El-Sisi
Anmol Singh Jaggi
Puneet Singh Jaggi
Sari Sabban
David Watkins
Simon Moon
Anas Algahtani
Matt Jones
Ayman Hamdan
Elon Musk
Allen Law
Xi Jinping
Anwar Hussain
Sultan Ibrahim ibni Sultan Iskandar
Prashant Joshi
Albinder Dhindsa